Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort

Myelin oligodendrocyte glycoprotein antibody associated disease (MOG-AD) is a CNS demyelinating disease, typically presenting with optic neuritis, transverse myelitis, and/or ADEM-like syndromes. The positive predictive value (PPV) of MOG-IgG testing by live cell-based assay was reported to be 72% i...

Full description

Bibliographic Details
Main Authors: Giovanna S. Manzano, Rebecca Salky, Farrah J. Mateen, Eric C. Klawiter, Tanuja Chitnis, Michael Levy, Marcelo Matiello
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Neurology
Subjects:
myelin oligodendrocyte glycoprotein (MOG)
MOG-AD
MOG-IgG
positive predictive value (PPV)
antibody testing
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.947630/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.947630/full

Similar Items